NGM raises $51 million
16 March 2010
Simon Varcoe
simon.varcoe@informa.com
NGM Biopharmaceuticals has closed the first tranche of a $51 million series B financing round to further its discovery platform based on biological insights into the effects of bariatric gastric bypass surgery and post-surgical resolution of type 2 diabetes and other metabolic disorders.
It...
Please Login to read the full article.